Import Refusal Records
503,850 FDA import refusal records
| Date | Firm | Country | Product | Violations |
|---|---|---|---|---|
| 9/3/2025 | Eli Lilly Italia SPA Sesto Fiorentino | ITALY | TIRZEPATIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | AstraZeneca UK Ltd. Macclesfield | UNITED KIN | DAPAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Glaxo Operations U.K. Ltd. Barnard Castle | UNITED KIN | BELIMUMAB | 75UNAPPROVED |
| 9/3/2025 | Patheon Italia S.p.A. Monza | ITALY | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 9/3/2025 | Bristol Myers Squibb Srl Anagni | ITALY | ABATACEPT | 75UNAPPROVED |
| 9/3/2025 | F. Hoffmann - La Roche Ltd. Kaiseraugst | SWITZERLAN | TOCILIZUMAB | 75UNAPPROVED |
| 9/3/2025 | Sanofi Winthrop Industrie Le Trait | FRANCE | DUPILUMAB | 75UNAPPROVED |
| 9/3/2025 | Boehringer Ingelheim Hellas A.E. Koropi | GREECE | EMPAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Lilly S.A. Alcobendas | SPAIN | BARICITINIB (ANTI-RHEUMATIC) | 75UNAPPROVED |
| 9/3/2025 | Cilag AG Schaffhausen | SWITZERLAN | USTEKINUMAB | 75UNAPPROVED |
| 9/3/2025 | Pfizer Health AB Strangnas | SWEDEN | ANAKINRA | 75UNAPPROVED |
| 9/3/2025 | Glaxo Operations UK Limited Ware | UNITED KIN | ANTI-ASTHMATIC, N.E.C. | 75UNAPPROVED |
| 9/3/2025 | Abbvie Biotechnology Gmbh Ludwigshafen Am Rhein | GERMANY | RISANKIZUMAB-RZAA | 75UNAPPROVED |
| 9/3/2025 | Vetter Pharma Fertigung GmbH & Co. KG Ravensburg | GERMANY | DULAGLUTIDE | 75UNAPPROVED |
| 9/3/2025 | Delpharm Meppel B.V. Meppel | NETHERLAND | MIRABEGRON (ADRENERGIC) | 75UNAPPROVED |
| 9/3/2025 | Bayer AG Leverkusen | GERMANY | RIVAROXABAN | 75UNAPPROVED |
| 9/3/2025 | Novartis Farma S.P.A. Torre Annunziata | ITALY | VALSARTAN (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED |
| 9/3/2025 | Sanofi Winthrop Industrie Tours | FRANCE | IMMUNOMODULATOR N.E.C. | 75UNAPPROVED |
| 9/3/2025 | AstraZeneca UK Ltd. Macclesfield | UNITED KIN | DAPAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Eli Lilly Italia SPA Sesto Fiorentino | ITALY | DULAGLUTIDE | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim am Rhein | GERMANY | ANTI-ASTHMATIC, N.E.C. | 75UNAPPROVED |
| 9/3/2025 | Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim am Rhein | GERMANY | EMPAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Pfizer Manufacturing Deutschland GmbH Freiburg Im Breisgau | GERMANY | APIXABAN (ANTI-COAGULANT) | 75UNAPPROVED |
| 9/3/2025 | Pfizer Manufacturing Deutschland GmbH Freiburg Im Breisgau | GERMANY | APIXABAN (ANTI-COAGULANT) | 75UNAPPROVED |
| 9/3/2025 | GlaxoSmithKline Manufacturing S.p.A. Torrile | ITALY | BELIMUMAB | 75UNAPPROVED |
| 9/3/2025 | GlaxoSmithKline Manufacturing S.p.A. Torrile | ITALY | BELIMUMAB | 75UNAPPROVED |
| 9/3/2025 | Glaxo Operations U.K. Ltd. Barnard Castle | UNITED KIN | BELIMUMAB | 75UNAPPROVED |
| 9/3/2025 | Wuxi Biologics Co Ltd Wuxi | CHINA | ANTINEOPLASTIC, NEC | 75UNAPPROVED |
| 9/3/2025 | Takeda GmbH, Plant Oranienburg Oranienburg | GERMANY | DENTAL PROTECTANT N.E.C. | 75UNAPPROVED |
| 9/3/2025 | Genzyme Ireland Limited Waterford | IRELAND | DUPILUMAB | 75UNAPPROVED |
| 9/3/2025 | Bayer AG Leverkusen | GERMANY | RIVAROXABAN | 75UNAPPROVED |
| 9/3/2025 | Swords Laboratories Unlimited Company Dublin 15 | IRELAND | INHIBITOR N.E.C. | 75UNAPPROVED |
| 9/3/2025 | Glaxo Operations UK Limited Ware | UNITED KIN | BRONCHODILATOR N.E.C. | 75UNAPPROVED |
| 9/3/2025 | Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim am Rhein | GERMANY | EMPAGLIFLOZIN (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Novo Nordisk A/S Bagsvard | DENMARK | SEMAGLUTIDE (ANTI-DIABETIC) | 75UNAPPROVED |
| 9/3/2025 | Swords Laboratories Unlimited Company Dublin 15 | IRELAND | NIVOLUMAB | 75UNAPPROVED |
| 9/3/2025 | Pfizer Manufacturing Belgium NV Puurs-Sint-Amands | BELGIUM | ETANERCEPT | 75UNAPPROVED |
| 9/3/2025 | Cilag AG Schaffhausen | SWITZERLAN | NIVOLUMAB | 75UNAPPROVED |
| 9/3/2025 | Novartis Pharma Stein AG Stein Ag | SWITZERLAN | SECUKINUMAB | 75UNAPPROVED |
| 9/3/2025 | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) Ravensburg | GERMANY | ADALIMUMAB | 75UNAPPROVED |
| 9/3/2025 | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) Ravensburg | GERMANY | VEDOLIZUMAB | 75UNAPPROVED |
| 9/3/2025 | F. Hoffmann - La Roche Ltd. Kaiseraugst | SWITZERLAN | OCRELIZUMAB | 75UNAPPROVED |
| 9/3/2025 | Bayer Viatal Gmbh Leverkusen | GERMANY | ASPIRIN (ANALGESIC) | 75UNAPPROVED |
| 9/3/2025 | Sanofi-Aventis De Mexico Ocoyoacac | MEXICO | FUROSEMIDE (DIURETIC) | 75UNAPPROVED |
About This Page
This page displays 50 FDA import refusal records from 14 countries. Records on this page involve violations including 75 (UNAPPROVED). Each record links to detailed firm profiles with complete violation history and risk assessments.
Viewing page 301 of 10,077 • Showing records 15,001-15,050 of 503,850 total